Interview of the Vice President (theresident expert on the closest. The o...)

Interview of the Vice President

Date:12/6/2007

the resident expert on the closest. The one that I think of, that was the summer before last, when plans were to launch out of I guess it was Heathrow, with explosives onboard aircraft and to do a major attack on several flights at once within a really relatively short period of time.

Q Mr. Vice President, how concerned are you about the threat from Islam within the United States? And specifically, how concerned are you about Iraqi immigrants that are coming here and the danger that they might pose?

THE VICE PRESIDENT: Well, you've got be very careful here not just to -- you don't want to assume somebody is an enemy or a threat because they're -- follow Islam or because they're from a particular part of the world. I think we work to make certain that we don't have those kinds of threats develop within the United States. I think we've been relatively successful at it.

We've got a large population of people of the Islamic faith in the United States. They are good, loyal Americans, important members of the community, and they're entitled to be judged, just like anybody else, based on their conduct, their activities.

Q Sir, did you believe the National Intelligence Estimate on Iran?

THE VICE PRESIDENT: Did I believe it?

Q Yes, do you believe the new one that's out -- or is there a reason to question those conclusions?

THE VICE PRESIDENT: I don't have any reason to question the -- what the community has produced, with respect to the NIE on Iran. Now, there are things they don't know. There are always -- there's always the possibility that the circumstances will change. But I think they've done the best job they can with the intelligence that's available to give us their best judgment on those issues.

Q Do you question the interpretation that many people have made upon the release of that?

THE VICE PRESIDENT: Interpretation?

Q Well, a lot of people are saying, well, look Iran was not the thre
'/>"/>

SOURCE White House Press Office
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
3. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
4. American Board of Internal Medicine President Named to Alzheimers Study Group

Post Your Comments:

(Date:5/21/2013)... , May 21, 2013 /PRNewswire-iReach/ -- The 2013 ... NJ has attracted the greatest number of "Emerging" ... President, Mark Alexay . "No ... to attend this year. The show,s still 4 months ... companies. This is a big surprise and great ...

(Date:5/21/2013)... , May 21, 2013 Decision ... and advisory firms for pharmaceutical and healthcare ... emerging agent on key efficacy endpoints, including ... has the most influence over surveyed U.S. ... hormone-receptor (HR-) positive, HER2-negative breast cancer. The ...

(Date:5/21/2013)... , May 21, 2013 IsoRay, Inc. (AMEX: ... it has entered into an exclusive international distribution agreement ... product line in Greece . IsoRay ... brachytherapy and medical radioisotope applications for brain cancer, lung ... ("gyn") cancer. IASIS Medical is ideally ...

Breaking Medicine Technology:Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2 Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2 IsoRay Announces A New International Distributor For Greece 2 IsoRay Announces A New International Distributor For Greece 3

[0] Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show [0] Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer [0] IsoRay Announces A New International Distributor For Greece

... , , BERLIN ... NKTR ) presented favorable data today on lead oncology program, ... investigational compound in ovarian cancer. These data were presented at ... Oncology (ESMO) 2009 Joint Multidisciplinary Congress in Berlin, Germany. , ...

... , , , ... a Phase II trial of regorafenib (BAY 73-4506), a potent oral multi-kinase ... partial response rate and 50 percent stabilization rate in patients with metastatic ... at the joint 15th Congress of the European CanCer Organisation and 34th ...

Cached Medicine Technology:NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress 2 NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress 3 NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress 4 NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress 5 Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients 2 Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients 3 Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients 4

NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients

(Date:5/21/2013)... 2013) Prostaglandin analogues (PGAs), drugs which lower intraocular ... people with glaucoma, but their use is not without ... dryness, changes in eye color and other side effects. ... also cause upper and lower eyelid drooping and other ... described in PLOS ONE . , Researchers from ...

(Date:5/21/2013)... Mecklenburg EMS Agency (Medic) and the ... Wellness Fair to educate the public on health initiatives and ... Wednesday, May 22, 2013 from 4:00 pm until 7:00 pm ... Creek Road, Charlotte, NC 29262). , Medic, the ... Mecklenburg County Department of Social Services are working toward ...

(Date:5/21/2013)... France: One-year results from SOURCE XT one of ... to-date reported today at EuroPCR 2013 show good ... of device success for all access approaches, valve sizes ... followed up 2688 consecutively enrolled patients (mean age 81.5 ... at 93 centres in 17 countries between July 2010 ...

(Date:5/21/2013)... According to a May 13, 2013 New Zealand ... Botox injections have become the most popular cosmetic ... to goo.gl/8iYbD). Although it is mostly associated with women, ... makes facial wrinkles less visible by paralyzing facial muscles. The ... months. This means that people who are conscious about their ...

(Date:5/21/2013)... 21, 2013 Phoseon Technology will present ... the 20th Annual IMI European Ink Jet Conference ... leader, Phoseon continues to invest in product development to ... of UV LED curing in printing applications. Phoseon ... the market offering both air cooled and water cooled ...

Breaking Medicine News(10 mins):Health News:Glaucoma drug can cause droopy eyelids 2 Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2 Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2

[0] Glaucoma drug can cause droopy eyelids [0] Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives [0] Post-approval TAVI registry shows high rates of device success at 1 year [0] Botox – Is the World’s Most Popular Cosmetic Procedure Safe?[0] Phoseon Technology Presents the Leading UV LED Curing Solutions at IMI European Ink Jet Conference

... Hospital,of Chicago (NOHC) is among the top five percent in ... Hospital Quality in,America study. The HealthGrades Research analyzed patient outcomes ... The study also,concluded that NOHC is:, -- ... A recipient of the HealthGrades Spine Surgery Excellence Award ...

... Facility is First New Maine Hospital in ... Global Med Technologies(R),Inc. (OTC Bulletin Board: GLOB), ... today that its Wyndgate,Technologies(R) division has signed ... of Brunswick, Maine, to license its SafeTrace ...

... between NanoHorizons and Hill-Rom delivers patient support ... with revolutionary antimicrobial technology, BATESVILLE, Ind., ... announced an agreement to incorporate,NanoHorizon,s antimicrobial technology ... be branded as "nanoAg+ (TM) with,SmartSilver(TM)", will ...

... new guideline on colorectal cancer screening released today ... of health care organizations, including the American College ... Endoscopy (ASGE) and the American Cancer Society (ACS), ... detection and states a strong preference for screening ...

... Naval Medical Center in Bethesda, Maryland Coincides, With Sleep Apnea ... ... Awareness Week, DALLAS, March 6 /PRNewswire/ - The observance ... for Dr. Keith Thornton,third-generation Dallas dentist and recognized expert on the treatment ...

... General Nutrition Centers, Inc.,("GNC" or the "Company"), the ... its financial results for the,quarter and year ended ... is an indirect wholly-owned subsidiary,of GNC Parent LLC, ... affiliates of,Ares Management LLC and Ontario Teachers, Pension ...

Neurologic & Orthopedic Hospital of Chicago Ranked Among Top in Nation for Spine Surgery Newest Hospital in New England Signs Agreement With Global Med Technologies(R), Inc.Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology New guidelines update recommendations on colorectal cancer screening Dallas Dentist Trains Navy Dentists on New Therapy to Treat Snoring and Obstructive Sleep Apnea General Nutrition Centers, Inc. Reports Fourth Quarter and Full Year 2007 Results

... The CritSpin whisper quiet, compact system ... clinic anywhere fast, accurate and cost effective ... Digital Reader, the CritSpin System offers a ... spin, complete cell packing - Meets NCCLS ...

... light over one smooth pulse duration, rather ... damage skin) that other technologies use. Palomar's ... water supply through the StarLux handpiece, down ... to as low as 4 degrees C. ...

Used to provide drainage of urine from the bladder. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Inte...

Used for stenting the urethra during hypospadias or epispadias repair and to promote postoperative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....

Medicine Products:

CritSpin Microhematocrit Centrifuge StarLux Pulsed Light and Laser System Silicone Foley Silicone Universal Drainage Stents